These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
16. Intestinal sterol transporters and cholesterol absorption inhibition. Davis HR; Tershakovec AM; Tomassini JE; Musliner T Curr Opin Lipidol; 2011 Dec; 22(6):467-78. PubMed ID: 22101558 [TBL] [Abstract][Full Text] [Related]
17. [Stanols--a new perspective in treatment of hypercholesterolemia?]. Jankowski P; Bilo G; Bryniarski L; Bryniarska-Mirek E; Pajak A Przegl Lek; 2000; 57(11):655-8. PubMed ID: 11293214 [TBL] [Abstract][Full Text] [Related]
18. Perspectives in cholesterol-lowering therapy: the role of ezetimibe, a new selective inhibitor of intestinal cholesterol absorption. Bruckert E; Giral P; Tellier P Circulation; 2003 Jul; 107(25):3124-8. PubMed ID: 12835406 [No Abstract] [Full Text] [Related]
19. Recent advances in the screening methods of NPC1L1 inhibitors. Zhang R; Liu W; Zeng J; Meng J; Shi L; Yang S; Chang J; Wang C; Xing K; Wen J; Liu N; Liang B; Xing D Biomed Pharmacother; 2022 Nov; 155():113732. PubMed ID: 36166964 [TBL] [Abstract][Full Text] [Related]
20. SREBP-1c gene polymorphism is associated with increased inhibition of cholesterol-absorption in response to ezetimibe treatment. Berthold HK; Laaksonen R; Lehtimäki T; Gylling H; Krone W; Gouni-Berthold I Exp Clin Endocrinol Diabetes; 2008 May; 116(5):262-7. PubMed ID: 18072016 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]